Amyotrophic Lateral Sclerosis Research
The clinical trials supported by Stichting TRICALS Foundation are centered on ALS, with a strong focus on outcomes relevant to survival and disease progression in people living with this neurodegenerative disorder.
- Overall survival in ALS
- Respiratory insufficiency and survival-related endpoints
- Placebo-controlled therapeutic evaluation
Research activity spans multiple collaborating sites across Europe, reflecting sustained involvement in motor neuron disease studies.
Neurodegenerative Disease Therapeutics
The sponsor’s funded studies address treatment options for motor neuron degeneration, with attention to therapies intended to influence the course of ALS and related functional decline.
- Disease-modifying therapy assessment
- Clinical outcomes in progressive neuromuscular disease
- Survival-focused intervention research
The therapeutic emphasis remains on interventions that may affect long-term outcomes in advanced neurological disease.
Multinational ALS Trial Network
Stichting TRICALS Foundation supports research conducted through a broad network of collaborating sites, enabling studies in several countries and reinforcing its role in coordinated ALS trial activity.
- Cross-border clinical collaboration
- Site-based recruitment in ALS studies
- European neuromuscular research coordination
This distributed research structure is closely tied to the evaluation of therapies for amyotrophic lateral sclerosis across diverse patient populations.
